Archive for the ‘wind’ tag

Mozobil launch ad

without comments

mozobil_launch_ad

Click on image to view ad details and full-size version on AdPharm

Ventavis in PAH

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

In Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Give your PAH patients a second wind

New Ventavis 20 mcg/mL
Shorter treatment times. Higher concentration.

The only inhaled PAH therapy to demonstrate a spectrum of PAH efficacy.

Smart technology from the I-neb AAD by Philips Respironics

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and ischaemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA.

More on Wikipedia

Brand name: Ventavis
Generic name/category: Iloprost, Prostaglandins, Alkynes
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Target: Healthcare Professionals (HCP)
Tagline: A spectrum of inhaled PAH efficacy
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: Chest – September 2009

To see all of this brand’s ads on AdPharm, click here

Toviaz – mosaic

without comments

Login or subscribe to view this ad

Now, a pill that comes with a plan.
Get the full picture in OAB care

Toviaz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome. It was approved by the European Medicines Agency in April 2007 and was approved by the US Food and Drug Administration on October 31, 2008.

Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.

More on Wikipedia

Brand name: Toviaz
Generic name/category: Fesoterodine, Muscarinic antagonists, Prodrugs
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Overactive bladder OAB
Target: Healthcare Professionals (HCP)
Tagline: Get the full picture in OAB care
Medium: Print ad
Size/duration: single-page
Publication/Aired: Urology Times – September 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 07, 2009

Visit AdPharm.net for more pharmaceutical ads

Inline Courier

without comments

Inline Courier
Not Pretty, But Fast

Advertising Agency: Scholz & Friends, Berlin, Germany
Creative Directors: Matthias Spaetgens, Oliver Handlos, Jan Leube
Art Director: Mathias Rebmann
Copywriter: Florian Schwalme
Photographer: Hans Starck
Post Production: Appel Grafik Berlin
Agency Producer: Soeren Gessat
Account Managers: Sven Weiche, Anna Gabriel

For more ads with anatomical visuals an AdPharm, click here.

Via I Believe in advertising

Written by AdPharm

January 6th, 2009 at 6:03 am